Friday, November 27, 2020

FedNet

Multimedia News Content Leader in Washington since 1996

Contact FedNet to purchase a verbatim transcript

Pharmaceutical Executives on Drug Prices

House Oversight and Reform Committee

Unsustainable Drug Prices: Testimony from the CEOs (Part I and Part II)

Wednesday September 30, 2020 10:00 a.m.

Room: 2154 Rayburn Bldg.

Mr. Mark Alles, Former Chairman of the Board / Chief Executive Officer, Celgene Corporation

Dr. Giovanni Caforio, Chairman of the Board / Chief Executive Officer, Bristol Myers Squibb Company

Mr. Kare Schultz, President / Chief Executive Officer, Teva Pharmaceutical Industries Ltd.